UK markets close in 49 minutes

Biodesix, Inc. (BDSX)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
1.8000+0.0500 (+2.86%)
As of 11:14AM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
38,212
38,212
54,506
45,557
24,552
Cost of revenue
14,154
14,154
30,518
21,998
6,074
Gross profit
24,058
24,058
23,988
23,559
18,478
Operating expenses
Research development
13,102
13,102
12,789
10,818
10,468
Selling general and administrative
61,462
61,462
50,517
34,857
30,637
Total operating expenses
74,564
74,564
63,306
45,675
41,105
Operating income or loss
-50,506
-50,506
-39,318
-22,116
-22,627
Interest expense
8,072
8,072
4,508
7,604
3,008
Total other income/expenses net
-6,869
-6,869
667
-1,648
-5,146
Income before tax
-65,447
-65,447
-43,159
-31,350
-30,726
Income from continuing operations
-65,447
-65,447
-43,159
-31,350
-30,726
Net income
-65,447
-65,447
-43,159
-31,350
-30,726
Net income available to common shareholders
-65,447
-65,447
-43,159
-31,350
-30,351
Basic EPS
-
-
-1.58
-6.48
-1.16
Diluted EPS
-
-
-1.58
-6.48
-1.16
Basic average shares
-
-
27,365
4,838
26,131
Diluted average shares
-
-
27,365
4,838
26,131
EBITDA
-
-51,531
-35,473
-20,843
-24,925